A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer

2015

Purpose To characterize the cardiovascular safety profile of regorafenib in patients with advanced cancer.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

15

References

16

Citations